Education
About Us
Working with TipRanks
Follow Us
Pivotal bioVenture Partners Fund I, L.P. Insider Profile
4 Followers
Pivotal bioVenture Partners Fund I, L.P., Ten Percent Owner at Entasis Therapeutics Holdings, holds 294.50K shares in Evommune, Inc. (Ticker: EVMN), holds 1.57M shares in Inozyme Pharma (Ticker: INZY), holds 1.79M shares in AKOUOS (Ticker: AKUS).
Pivotal bioVenture Partners Fund I, L.P. Entasis Therapeutics Holdings (ETTX)Ten Percent Owner
Entasis Therapeutics Holdings (ETTX)
Ten Percent Owner
Ranked #69,519 out of 104,310 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-9.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Pivotal bioVenture Partners Fund I, L.P.'s holdings
Insider Roles
Director, Ten Percent Owner
Roles that Pivotal bioVenture Partners Fund I, L.P. holds in companies
Most Profitable Insider Trade
Stock:
Inozyme Pharma
(INZY)
(INZY)
Rating:Informative Buy
Date:Apr 20, 2022 - Apr 20, 2023
Return:+30.30%
The most profitable trade made by Pivotal bioVenture Partners Fund I, L.P.
Pivotal bioVenture Partners Fund I, L.P.'s Trading History
Entasis Therapeutics Holdings
Oct 02, 2018
―
Uninformative Buy
―
$2.58M
AKOUOS
Jul 01, 2020
―
Uninformative Buy
―
$23.84M
Inozyme Pharma
Aug 03, 2023
―
Informative Buy
4.00M
$6.29M
Evommune, Inc.
Nov 12, 2025
Director, Ten Percent Owner
Uninformative Buy
―
$5.39M
List of latest transactions for each holding click on a transaction to see Pivotal bioVenture Partners Fund I, L.P.'s performance on stock
You May Also Like
Pivotal bioVenture Partners Fund I, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Pivotal bioVenture Partners Fund I, L.P.?
The percentage of profitable transactions made by Pivotal bioVenture Partners Fund I, L.P. is 40%.
What is the average return per transaction made by Pivotal bioVenture Partners Fund I, L.P.?
The average return per transaction made by Pivotal bioVenture Partners Fund I, L.P. is -9.70%.
What stocks does Pivotal bioVenture Partners Fund I, L.P. hold?
Pivotal bioVenture Partners Fund I, L.P. holds: ETTX, AKUS, INZY, EVMN stocks.
What was Pivotal bioVenture Partners Fund I, L.P.’s latest transaction?
Pivotal bioVenture Partners Fund I, L.P. latest transaction was an Uninformative Buy of ―.
What was Pivotal bioVenture Partners Fund I, L.P.'s most profitable transaction?
Pivotal bioVenture Partners Fund I, L.P.’s most profitable transaction was an Informative Buy of INZY stock on April 20, 2022. The return on the trade was 30.30%.
What is Pivotal bioVenture Partners Fund I, L.P.'s role in Entasis Therapeutics Holdings?
Pivotal bioVenture Partners Fund I, L.P.'s role in Entasis Therapeutics Holdings is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.